Efficacy and Safety Outcomes of Catheter Ablation of Non-valvular Atrial Fibrillation in Korean Practice: Analysis of Nationwide Claims Data
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Objectives: The aim of this study was to investigate the effectiveness and selected adverse events of radiofrequency catheter ablation in patients treated for drug-refractory atrial fibrillation (AF) using claims data provided by the Health Insurance Review and Assessment Service, which covers all ablation procedures conducted in South Korea. Subjects and Methods: The study population included patients who underwent catheter ablation for AF between January 2011 and December 2013. A total of 3,850 patients without a previous history of catheter ablation procedure were enrolled. We analyzed 2-year effectiveness of the index ablation. Any redo ablation, electrical cardioversion, or use of antiarrhythmic drug beyond the blanking period of 3 months was considered a failure of index ablation. Results: Overall recurrence rate following AF ablation was 61.1%. The recurrence rate was lower in patients under 65 years old than in those over 65 years old (hazard ratio [HR] 0.89; 95% confidence interval [CI], 0.81 to 0.97, P=0.009). Repeat ablation was more frequent in men (HR 1.56; 95% CI, 1.20 to 2.04; P=0.001) and patients under 65 years old (HR 1.79; 95% CI, 1.34 to 2.38; P<0.001). Electric cardioversion was more frequent in men (HR 1.35; 95% CI, 1.06 to 1.72; P=0.014) than in women. The overall rate of stroke, blood transfusion, significant pericardial complication, and cardiopulmonary resuscitation was 0.5%, 4.8%, 2.7%, and 0.2%, respectively. Conclusions: In the present study, old age was associated with treatment failure of catheter ablation for drug-refractory AF in the Korean population. Overall recurrence did not vary with respect to sex.
Abstract
Background and Objectives: The aim of this study was to investigate the effectiveness and selected adverse events of radiofrequency catheter ablation in patients treated for drug-refractory atrial fibrillation (AF) using claims data provided by the Health Insurance Review and Assessment Service, which covers all ablation procedures conducted in South Korea. Subjects and Methods: The study population included patients who underwent catheter ablation for AF between January 2011 and December 2013. A total of 3,850 patients without a previous history of catheter ablation procedure were enrolled. We analyzed 2-year effectiveness of the index ablation. Any redo ablation, electrical cardioversion, or use of antiarrhythmic drug beyond the blanking period of 3 months was considered a failure of index ablation. Results: Overall recurrence rate following AF ablation was 61.1%. The recurrence rate was lower in patients under 65 years old than in those over 65 years old (hazard ratio [HR] 0.89; 95% confidence interval [CI], 0.81 to 0.97, P=0.009). Repeat ablation was more frequent in men (HR 1.56; 95% CI, 1.20 to 2.04; P=0.001) and patients under 65 years old (HR 1.79; 95% CI, 1.34 to 2.38; P<0.001). Electric cardioversion was more frequent in men (HR 1.35; 95% CI, 1.06 to 1.72; P=0.014) than in women. The overall rate of stroke, blood transfusion, significant pericardial complication, and cardiopulmonary resuscitation was 0.5%, 4.8%, 2.7%, and 0.2%, respectively. Conclusions: In the present study, old age was associated with treatment failure of catheter ablation for drug-refractory AF in the Korean population. Overall recurrence did not vary with respect to sex.
참고문헌 (22)
- Kirchhof P, "2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS", Europace, 18, pp.1609~1678 (2016)[DOI]
- January CT, "2014 AHA", ACC, American Heart Association Task Force on practice guidelines and the Heart Rhythm Society, pp.J Am Coll Cardiol, 2014[DOI]
- 서기현, "Risk of Hip Fractures in Men with Alpha-Blockers: A Nationwide Study Base on Claim Registry", 대한골대사학회지, 22(1), pp.29~32 (2015), 대한골대사학회[DOI]
- Nyong J, "Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation", Cochrane Database Syst Rev, 11 (2016)
- Morillo CA, "Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial", JAMA, 311, pp.692~700 (2014)[DOI]
- Cosedis Nielsen J, "Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation", N Engl J Med, 367, pp.1587~1595 (2012)[DOI]
- Khan AR, "Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis", Circ Arrhythm Electrophysiol, 7, pp.853~860 (2014)[DOI]
- Ganesan AN, "Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis", J Am Heart Assoc, 2, pp.e004549~ (2013)
- Bertaglia E, "Twelve-year follow-up of catheter ablation for atrial fibrillation: A prospective, multicenter, randomized study", Heart Rhythm, 14, pp.486~492 (2016)
- Haissaguerre M, "Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci", Circulation, 101, pp.1409~1417 (2000)[DOI]
- Kuck KH, "Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial", Circ Arrhythm Electrophysiol, 9, pp.e003337~ (2016)[DOI]
- Verma A, "Approaches to catheter ablation for persistent atrial fibrillation", N Engl J Med, 372, pp.1812~1822 (2015)[DOI]
- Dong JZ, "Prospective randomized comparison between a fixed '2C3L' approach vs. stepwise approach for catheter ablation of persistent atrial fibrillation", Europace, 17, pp.1798~1806 (2015)[DOI]
- Scott PA, "The impact of adjunctive complex fractionated atrial electrogram ablation and linear lesions on outcomes in persistent atrial fibrillation: a meta-analysis", Europace, 18, pp.359~367 (2016)[DOI]
- Calkins H, "2012 HRS", EHRA, J Interv Card Electrophysiol, pp.2012, 33[DOI]
- Van Brabandt H, "Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data", Europace, 15, pp.663~668 (2013)[DOI]
- Akoum N, "Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach", J Cardiovasc Electrophysiol, 22, pp.16~22 (2011)[DOI]
- McCready JW, "Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation", Europace, 13, pp.355~361 (2011)[DOI]
- Berruezo A, "Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation", Eur Heart J, 28, pp.836~841 (2007)[DOI]
- Zhang XD, "The impact of age on the efficacy and safety of catheter ablation for long-standing persistent atrial fibrillation", Int J Cardiol, 168, pp.2693~2698 (2013)[DOI]
- Takigawa M, "Differences in catheter ablation of paroxysmal atrial fibrillation between males and females", Int J Cardiol, 168, pp.1984~1991 (2013)[DOI]
- Cappato R, "Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation", Circ Arrhythm Electrophysiol, 3, pp.32~38 (2010)[DOI]